Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kendall Research Systems was a private neurotechnology and healthcare tools company that developed hardware instrumentation and software for in vivo neuroscience research. The company was known for pioneering wireless optogenetics and neural interface technologies used in pharmaceutical research and translational neuroscience. Its offerings appear to have focused on implantable optics, head-borne controllers, wireless data access, and related bioinstrumentation rather than a therapeutic drug pipeline. Founded in 2011, the company was acquired by Kernel on February 22, 2017. Following the acquisition, Kendall Research Systems appears to have ceased operating as an independent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kendall Research Systems.